Does Aetna Cover Depression Treatment in West Virginia? A 2026 Guide

Last updated: July 15, 2026

Considering depression treatment in West Virginia? Aetna members in the Mountain State may have meaningful coverage for therapy, medication management, and intensive outpatient care. See if Aetna may cover your depression treatment through Klarity Health — same-week appointments available with 2,000+ licensed providers.

Depression is one of the most common and most treatable mental health conditions — yet navigating insurance coverage can feel like a second diagnosis. If you have Aetna coverage in West Virginia, this guide breaks down what depression treatment benefits may look like, how the CVS/Caremark formulary typically handles antidepressants, what prior authorization requirements may apply, and how West Virginia’s mental health parity law protects your access to care.

Does Aetna Cover Depression Treatment in West Virginia?

Aetna’s fully insured commercial plans sold in West Virginia are regulated under state insurance law and must comply with both the federal Mental Health Parity and Addiction Equity Act (MHPAEA) and West Virginia’s mental health parity statute, W. Va. Code § 33-25-8r et seq. This typically means that if Aetna covers medical and surgical conditions, it must offer comparable coverage for mental health conditions such as major depressive disorder (MDD), persistent depressive disorder (dysthymia), postpartum depression, and treatment-resistant depression.

Coverage often includes:

• Psychiatric evaluation and diagnostic assessment
• Outpatient individual therapy (CBT, IPT, behavioral activation, psychodynamic, DBT, ACT)
• Telehealth therapy and medication management
• Intensive outpatient programs (IOP)
• Partial hospitalization programs (PHP)
• Inpatient psychiatric care for acute episodes
• Medication management visits with a prescribing clinician
• Antidepressant medications through CVS/Caremark pharmacy benefits

Actual coverage depends on your specific Aetna plan, your employer’s benefit design (if applicable), whether your provider is in-network, and whether prior authorization is required. Always verify your benefits before scheduling.

Aetna Plan Types Available in West Virginia

Aetna offers several commercial plan structures in West Virginia. The plan type affects whether you need a referral and how you access mental health specialists:

• Aetna Choice POS II: A point-of-service plan that typically does not require a referral for in-network mental health providers. Members may self-refer to in-network psychiatrists, therapists, and prescribers.
• Aetna Select: An HMO-style plan that may require a primary care physician referral before seeing a specialist, including a psychiatrist. Confirm your plan’s referral requirement before booking.
• Aetna Open Choice PPO: A preferred provider organization plan that generally allows direct access to any licensed in-network provider. Out-of-network benefits may be available at higher cost-sharing.
• ACA Marketplace Plans: Aetna participates in the West Virginia ACA Marketplace (healthcare.gov). Marketplace plans include mental health and substance use disorder treatment as an Essential Health Benefit under federal law, meaning depression treatment coverage is included in all metal tier plans.

West Virginia Mental Health Parity Law

West Virginia’s mental health parity law, W. Va. Code § 33-25-8r et seq., requires that fully insured health insurance policies issued in West Virginia provide mental health and substance use disorder benefits that are no more restrictive than the plan’s medical and surgical benefits. This applies to:

• Financial requirements (deductibles, copayments, coinsurance, out-of-pocket limits)
• Treatment limitations (visit limits, day limits, frequency restrictions)
• Non-quantitative treatment limitations (NQTLs) such as prior authorization criteria, step therapy requirements, and network access standards

In practice, this means Aetna typically cannot impose higher copayments for therapy visits than for equivalent medical visits, cannot apply stricter prior authorization standards to antidepressants than to comparable medical medications, and cannot limit the number of therapy visits while imposing no equivalent limit on medical office visits.

ERISA self-funded employer carve-out: W. Va. Code § 33-25-8r applies to fully insured commercial plans regulated by the West Virginia Insurance Commissioner. Self-funded ERISA plans — common among large West Virginia employers in the natural gas, coal, chemical manufacturing, and government contracting sectors — are governed by federal MHPAEA rather than state parity law. If you are enrolled through a large employer’s self-funded plan, the parity protections are federal. Members of self-funded plans may request a written comparison of their plan’s non-quantitative treatment limitations (NQTLs) under MHPAEA. Contact Aetna member services to determine if your plan is fully insured or self-funded.

Ready to connect with a depression specialist? Klarity Health works with 2,000+ licensed providers across West Virginia and all 50 states. Check if your Aetna plan may cover online depression treatment through Klarity Health.

CVS/Caremark Antidepressant Formulary (2026)

Aetna members in West Virginia use CVS/Caremark as their pharmacy benefit manager (PBM). CVS/Caremark’s commercial formulary for antidepressants in 2026 typically follows a tiered structure. Actual tier placement and prior authorization requirements may vary by specific plan design — always verify your plan’s formulary through your Aetna member portal or by calling CVS/Caremark.

Note: Tier placement and prior authorization requirements can vary significantly between plan designs. Verify your specific benefits through the Aetna member portal (member.aetna.com) or by calling CVS/Caremark at 1-800-552-8159.

Electronic Prescribing for Controlled Substances (EPCS) in West Virginia

West Virginia has one of the broadest electronic prescribing for controlled substances (EPCS) mandates in the United States. Under W. Va. Code § 60A-4-403a, the EPCS requirement applies to all schedules of controlled substances — not just Schedule II as in most other states. This has specific implications for depression treatment involving certain medications.

Standard antidepressants — EPCS entirely inapplicable: The vast majority of antidepressant medications are not controlled substances. SSRIs (sertraline, fluoxetine, escitalopram, citalopram, paroxetine), SNRIs (venlafaxine, duloxetine, desvenlafaxine), bupropion, mirtazapine, trazodone, tricyclic antidepressants (amitriptyline, nortriptyline), vortioxetine (Trintellix), and dextromethorphan-bupropion (Auvelity) are all non-scheduled. W. Va. Code § 60A-4-403a does not apply to these medications — they may be prescribed via standard electronic prescribing, phone-in to pharmacies, or written prescription as clinically appropriate.

Spravato (esketamine) — Schedule III, EPCS applies: Spravato is a Schedule III controlled substance. Under W. Va. Code § 60A-4-403a’s all-controlled-substances mandate, EPCS applies to Spravato prescriptions in West Virginia. However, Spravato is subject to the FDA Risk Evaluation and Mitigation Strategy (REMS) program, which requires that it be administered by healthcare providers in a certified healthcare setting — patients cannot take it home. In practice, the EPCS requirement for Spravato is managed at the facility level, not as an outpatient-prescriber-to-retail-pharmacy prescription. If you are being evaluated for treatment-resistant depression and Spravato is under consideration, your provider’s care team will manage the prescribing and REMS compliance requirements.

Prior Authorization for Depression Treatment

Prior authorization (PA) is Aetna’s process for reviewing whether a treatment or medication meets medical necessity criteria before approving coverage. For depression treatment in West Virginia, PA may apply in several contexts:

• Brand-name antidepressants: If your prescriber recommends a brand-name SSRI or SNRI when a generic equivalent is available, PA or step therapy documentation (showing the generic was tried and ineffective or caused adverse effects) may be required.
• Trintellix (vortioxetine) and Auvelity: These newer antidepressants typically require PA demonstrating that first-line generic antidepressants were trialed and failed.
• Spravato (esketamine): PA is required for Spravato, and treatment must occur in a certified healthcare facility under the REMS program. PA criteria typically include documented treatment-resistant depression (failure of two or more adequate antidepressant trials) and physician attestation of medical necessity.
• Intensive outpatient programs (IOP) and partial hospitalization programs (PHP): PA is typically required for IOP and PHP levels of care. Aetna will review clinical documentation to confirm the level of care is medically necessary.
• Inpatient psychiatric admission: PA (often concurrent review) is typically required for inpatient psychiatric care.

WV SB 267 (2024) — Electronic PA via Availity required: West Virginia Senate Bill 267, enacted in 2024, requires that all prior authorization requests to health insurers in West Virginia be submitted electronically through certified PA portals. For Aetna WV commercial plans, the designated electronic PA portal is Availity (availity.com). Paper PA forms are no longer accepted by Aetna WV. If your provider submits PA requests for depression treatment, they must use the Availity platform.

PA response timelines:

• Standard PA: Typically 2–3 business days
• Urgent/expedited PA (clinical urgency documented): Typically 24–72 hours
• Appeal window if denied: Typically 60 days from denial notice (internal appeal); external review rights available under West Virginia law

Depression Treatment Options That May Be Covered

Aetna’s behavioral health benefits for depression in West Virginia typically encompass a range of evidence-based treatment modalities:

• Cognitive Behavioral Therapy (CBT): The most extensively studied psychotherapy for depression. In-network therapists who provide CBT are typically covered under your behavioral health benefit.
• Interpersonal Therapy (IPT): Effective for depression linked to grief, role transitions, and relationship difficulties.
• Behavioral Activation (BA): A structured therapy component targeting reduced activity and isolation common in depression.
• Problem-Solving Therapy (PST): Often used in primary care settings and via telehealth for depression with functional impairment.
• Psychodynamic Therapy: May be covered for longer-term treatment of complex depressive presentations; coverage duration varies by plan.
• Dialectical Behavior Therapy (DBT): May be covered for depression with co-occurring emotional dysregulation or borderline features.
• Telehealth therapy and medication management: Aetna typically covers telehealth behavioral health visits on par with in-person visits under W. Va. Code § 33-25-8r and MHPAEA telehealth parity requirements. Online prescribing for depression medications (non-controlled antidepressants) is available through platforms like Klarity Health.
• Medication management visits: Follow-up visits with a prescribing provider (psychiatrist, APRN, PA) for antidepressant monitoring and adjustment.
• Intensive Outpatient Program (IOP): Structured group and individual therapy, typically 3 hours/day, 3–5 days/week. Covered with PA for eligible members.
• Partial Hospitalization Program (PHP): More intensive than IOP, typically 5–6 hours/day. Covered with PA as an alternative to inpatient care.

How to Verify Your Aetna Depression Benefits in West Virginia

Before booking a provider or filling a prescription, take these steps to understand your actual coverage:

1. Log in to member.aetna.com and navigate to “Benefits Summary” or “Behavioral Health Benefits.” Review your deductible, copay, and any visit limits for outpatient mental health services.
2. Check the CVS/Caremark drug formulary at caremark.com or by calling 1-800-552-8159. Search for your specific antidepressant by name to confirm its tier and any PA requirements.
3. Confirm your plan type (HMO/POS vs. PPO) to determine whether a referral is required for a psychiatrist or specialist prescriber.
4. Verify provider network status by searching Aetna’s provider directory at aetna.com/find-a-doctor before scheduling. Out-of-network providers may not be covered, or may be covered at a higher cost-share under PPO plans.
5. Call Aetna member services at 1-800-872-3862 with specific questions about PA requirements, benefit limits, or to confirm whether your plan is fully insured or self-funded (ERISA).

Skip the insurance navigation maze. Klarity Health’s intake team can help verify whether your Aetna plan may cover online depression treatment. Start with Klarity Health — 2,000+ licensed providers, same-week appointments.

Depression Treatment at Klarity Health

Klarity Health offers online depression treatment with licensed psychiatrists, psychiatric nurse practitioners, and therapists across West Virginia and all 50 states. Our providers offer evaluation, diagnosis, therapy, and antidepressant prescribing — all via telehealth, from your home.

Key details for West Virginia patients:

• All prescribers in Klarity Health’s network are licensed and in compliance with West Virginia’s EPCS requirements for controlled substances
• Standard antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, etc.) may be prescribed via telehealth — no in-person visit required
• Klarity Health’s intake team can help you understand whether your Aetna plan may cover services and connect you with in-network providers where available
• 2,000+ licensed providers available for mental health evaluation and ongoing care
• Same-week appointments often available

Coverage through Aetna may vary by plan. Klarity Health recommends verifying your behavioral health benefits before your first appointment.

Frequently Asked Questions

Does Aetna require a referral to see a psychiatrist for depression in West Virginia?

It depends on your plan type. Aetna Choice POS II and Open Choice PPO plans typically allow you to self-refer to an in-network psychiatrist or psychiatric prescriber without first seeing your primary care physician. Aetna Select (HMO-style) plans may require a PCP referral. Check your plan documents or call Aetna at 1-800-872-3862 to confirm your plan’s referral requirements before scheduling.

Does Aetna cover Spravato (esketamine) for treatment-resistant depression in West Virginia?

Spravato may be covered under Aetna’s specialty drug benefit for members with documented treatment-resistant depression (typically defined as failure of two or more adequate antidepressant trials at therapeutic doses). Prior authorization is required. Spravato must be administered in a certified healthcare facility under the FDA REMS program — it cannot be prescribed as a take-home medication. Coverage approval depends on your specific plan’s clinical criteria. Contact Aetna at 1-800-872-3862 or your treating provider’s office for PA guidance.

Does West Virginia’s parity law apply to my Aetna plan?

If you have a fully insured Aetna plan purchased through the ACA Marketplace or directly from Aetna in West Virginia, W. Va. Code § 33-25-8r et seq. applies. This law requires that mental health benefits be offered on parity with medical and surgical benefits. If you are enrolled through a large employer’s self-funded benefit plan, federal MHPAEA applies instead. Call Aetna at 1-800-872-3862 to confirm whether your plan is fully insured or self-funded.

Do I need to worry about EPCS for my antidepressant prescription in West Virginia?

For the vast majority of antidepressants, no — EPCS does not apply. SSRIs, SNRIs, bupropion, mirtazapine, trazodone, TCAs, Trintellix, and Auvelity are all non-scheduled medications. Your prescribing provider can transmit these prescriptions through standard electronic prescribing (or other allowed methods) without EPCS compliance. West Virginia’s W. Va. Code § 60A-4-403a EPCS mandate applies only to controlled substances. The only depression-related medication where EPCS applies is Spravato (esketamine, Schedule III), and in that case it is managed at the treatment facility level under the FDA REMS program.

What can I do if Aetna denies a PA request for my antidepressant or therapy?

You have the right to appeal a prior authorization denial. Key steps: (1) Request a written explanation of the denial and the clinical criteria used. (2) Have your provider submit a peer-to-peer review request to Aetna’s medical director — this often resolves denials for evidence-based medications. (3) File a formal internal appeal within 60 days of the denial notice. (4) If the internal appeal is denied, request an external independent medical review under West Virginia law. (5) If you believe the denial violates mental health parity requirements, contact the West Virginia Insurance Commissioner at 1-888-879-9842. For parity-related concerns, you may also request that Aetna provide a written comparison of its NQTL criteria for mental health versus medical/surgical benefits.

Helpful Contacts

• Aetna Member Services: 1-800-872-3862 (on the back of your Aetna insurance card)
• CVS/Caremark Pharmacy Benefits: 1-800-552-8159
• Aetna Member Portal: member.aetna.com
• West Virginia Insurance Commissioner: 1-888-879-9842 (for parity complaints and external review)
• SAMHSA National Helpline: 1-800-662-4357 (free, confidential, 24/7 mental health referrals)
• 988 Suicide and Crisis Lifeline: Call or text 988 (available 24/7)

Disclaimer: Insurance coverage for depression treatment varies by plan, employer benefit design, provider network status, and clinical criteria. The information in this guide reflects general Aetna and CVS/Caremark practices as of 2026 and is intended for informational purposes only. Always verify your specific benefits with Aetna at 1-800-872-3862 or through member.aetna.com before scheduling treatment or filling a prescription. This content does not constitute medical or legal advice. Coverage determinations are made by Aetna based on your individual plan terms.